Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
83.63
+4.56 (5.76%)
At close: Feb 10, 2026, 4:00 PM EST
82.12
-1.50 (-1.80%)
After-hours: Feb 10, 2026, 6:48 PM EST
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $89.51 million as of February 10, 2026. Its market cap has increased by 467.47% in one year.
Market Cap
89.51M
Enterprise Value
75.31M
1-Year Change
467.47%
Ranking
Category
Stock Price
$83.63
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $89.51M, a decrease of -76.35%. That is a compound annual growth rate of -23.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 84.63M | -9.23% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision BioSciences | 91.71M |
| Equillium | 91.34M |
| Champions Oncology | 90.96M |
| aTyr Pharma | 88.14M |
| eXoZymes | 87.57M |
| Immunic | 85.88M |
| Pyxis Oncology | 85.30M |
| OKYO Pharma | 80.70M |